Skip to content

Effects of Photobiomodulation on heart rate variability responses in bodybuilders

Assessment of heart rate variability in bodybuilders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5tkh5hv
Enrollment
Unknown
Registered
2023-06-06
Start date
2022-11-14
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise

Interventions

This is an acute clinical intervention study, randomized and controlled, that is, the effects of a given therapeutic approach (photobiomodulation) will be tested in a population of volunteers, with th
E02.774

Sponsors

Universidade Brasil
Lead Sponsor
Universidade Brasil
Collaborator

Eligibility

Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Non-athletes, who practice light physical activities (according to the perceived effort scale proposed by Borg (2000). Both sexes and who do not have a history of musculoskeletal injury in the regions of the arms, hips and knees; Age between 18 and 50 years and who can give informed consent; Physical exercise training for at least 03 months; Healthy individuals who do not have contraindications to Photobiomodulation Therapy (FBM)

Exclusion criteria

Exclusion criteria: Chronic alcoholic or who frequently ingest caffeine products; vasodilators, psychotropics and anti-inflammatory drugs; Individuals with neurological and muscular diseases; Pain or limitation in movements of the upper or lower limbs and suffered some type of serious injury in the last six months; Having chronic systemic diseases, for example, diabetes mellitus, systemic hypertension, cardiovascular, renal, brain diseases, neoplasms or HIV-AIDS; Cognitive inability to understand or communicate important

Design outcomes

Primary

MeasureTime frame
To evaluate the differences with and without photobiomodulation on cardiac autonomic modulation in bodybuilders at rest and after physical exercise. The primary outcome is heart rate variability (HRV) in 34 participants.

Secondary

MeasureTime frame
No secondary outcomes expected.

Countries

Brazil

Contacts

Public ContactWellington Silva

Universidade Brasil

saude@guarai.to.vog.br+55 (63) 3464-2121

Outcome results

None listed

Source: REBEC (via WHO ICTRP)